Skip to main content
Signal8

vVARDIS Holding AG (VVVV)

vVARDIS Holding AG, a dental medtech company, develops and provides non-invasive cavity treatment products in Switzerland and the United States. The company offers the Curodont platform, including Curodont Repair, a biomimetic system to arrest and reverse early caries through enamel regeneration; Curodont Protect, a remineralising tooth gel containing the biomimetic Oligo-Peptide 103 technology; and Enamel Serum, enriched with peptides and hydroxyapatite, which delivers calcium and phosphate ions to care for the enamel. The company was incorporated in 2020 and is based in Zug, Switzerland. vVARDIS Holding AG operates as a subsidiary of VVARDIS Investment Holding AG.

Sector: Surgical & Medical Instruments & Apparatus

Industry: Medical - Specialties

vVARDIS HOLDING AG Class A logo

vVARDIS HOLDING AG Class A

NYSE:VVVVHealthcare
-1.25%$15.80
CLOSED
AH$15.80+0.00%vs close
Mkt Cap$2.86B
EV-
Float1.69M
O/S181.09M
VOL162K sh
$ Vol$2.57M
RVOL0.10×
Inst Own-
Net Cash/Sh-
Dilution
vVARDIS HOLDING AG Class A logoNYSE:VVVVClosed$15.80-1.25%
Financials Summary

No financial data available.

Debt & Equity

No debt & equity data available.

Shares Outstanding
Short Interest

No short interest data available.

Split History

No splits on record

Nothing in VVVV's public trading history: no forward or reverse split has affected the share count.

Balance Sheet Details

No balance sheet details available.

Income Statement

No income statement data available.

Balance Sheet

No balance sheet data available.

Cash Flow Statement

No cash flow data available.